Inflammatory Bowel Diseases
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 1345
Editor
Interests: inflammatory bowel disease; clinical research; public health; nursing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We announce this Special Issue focused on the microbial dimensions of inflammatory bowel diseases (IBDs). IBDs, including Crohn’s disease and ulcerative colitis, are complex immune-mediated disorders in which alterations to the intestinal microbiota play a central role in disease onset, progression, and therapeutic response.
This Special Issue will provide a focused platform for high-quality research addressing the microbiological and microbial-driven mechanisms underlying IBDs. We welcome original research articles, reviews, and short communications exploring host–microbiome interactions, gut microbiota dysbiosis, microbial signatures associated with disease phenotypes, and the role of specific pathogens in intestinal inflammation.
Recent advances have highlighted the importance of microbial ecosystems in shaping mucosal immunity and influencing disease trajectories. Studies investigating bacterial, viral, and fungal communities, as well as multi-omics approaches integrating metagenomics, metabolomics, and transcriptomics, are contributing to a deeper understanding of IBD pathogenesis. In parallel, growing attention is being paid to antimicrobial resistance patterns in IBD patients, particularly in the context of repeated antibiotic exposure and immunosuppressive therapies.
This Special Issue also encourages contributions focusing on microbiome-based diagnostic and therapeutic strategies, including microbial biomarkers for early diagnosis and disease monitoring; microbiota-targeted interventions such as fecal microbiota transplantation, probiotics, prebiotics, and diet–microbiome interactions; and the development of precision medicine approaches based on microbial profiling.
Topics of interest include, but are not limited to, the following:
- Gut microbiota dysbiosis in IBDs;
- Host–microbiome interactions and immune regulation;
- Role of pathogens in intestinal inflammation;
- Antimicrobial resistance in IBD populations;
- Microbial biomarkers for diagnosis and prognosis;
- Microbiome-based therapeutic strategies;
- Multi-omics and systems biology approaches in IBD microbiology.
By focusing on the microbial determinants of IBD, this Special Issue will advance mechanistic understanding and support the development of innovative diagnostic and therapeutic approaches in this rapidly evolving field.
We look forward to receiving your contributions.
You may choose our Joint Special Issue in Microbiology Research.
Dr. Daniele Napolitano
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease
- Crohn’s disease
- ulcerative colitis
- gut microbiota
- dysbiosis
- microbiome
- intestinal inflammation
- microbial biomarkers
- antimicrobial resistance
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
